stock
NAMS · NewAmsterdam Pharma Co N.V.
What NewAmsterdam Pharma Co N.V. reports to the SEC, read from its filings.
Open in the appPrice
The live NAMS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on NAMS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 119,537,169 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -3432.2%
- Net
- -3632.7%
Returns
- ROE
- -41.0%
- ROA
- -36.7%
Health
- Current ratio
- 9.0x
- Debt/equity
- —
Deep value
- NCAV
- $586.18M
- NCAV per share
- $4.90
- Price/NCAV
- Locked
- NNWC
- $351.12M
- NNWC per share
- $2.94
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $3.70M | —Gross profit: unreported by this company. | -$64.86M | -$64.14M | 10-Q filed 2026-08-05 |
| 2026-03-31 | $3.04M | —Gross profit: unreported by this company. | -$58.42M | -$48.44M | 10-Q filed 2026-05-07 |
| 2025-12-31 | $32,000 | —Gross profit: unreported by this company. | -$65.98M | -$74.10M | DEF 14A filed 2026-05-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $348,000 | —Gross profit: unreported by this company. | -$55.14M | -$72.00M | 10-Q filed 2025-11-05 |
| 2025-06-30 | $19.14M | —Gross profit: unreported by this company. | -$35.63M | -$17.36M | 10-Q filed 2026-08-05 |
| 2025-03-31 | $2.98M | —Gross profit: unreported by this company. | -$68.92M | -$39.53M | 10-Q filed 2026-05-07 |
| 2024-12-31 | $12.77M | —Gross profit: unreported by this company. | -$43.23M | -$92.58M | DEF 14A filed 2026-05-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $29.11M | —Gross profit: unreported by this company. | -$25.00M | -$16.65M | 10-Q filed 2025-11-05 |
- Assets
- $704.45M
- Equity
- $631.42M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $22.50M | -$225.68M | -$203.00M | — |
| 2024-12-31 | $45.56M | -$176.29M | -$242.00M | — |
| 2023-12-31 | $14.09M | -$182.97M | -$177.00M | — |
| 2022-12-31 | $102.69M | -$3.56M | -$22.63M | — |
| 2021-12-31 | — | -$34.98M | -$41.78M | — |
Company filings
events
5% owners ()
Frazier Life Sciences X, L.P.
Stake update
FMR LLC
Stake update
Capital World Investors
Stake update
BCLS Fund III Investments, LP
Stake update
FMR LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Kastelein Johannes Jacob Pieter
Chief Scientific Officer, Director
Sale$1,257,657Oct 2, 4:30 PM ET
Davidson Michael H.
Chief Executive Officer, Director
Buy$226,500Sep 15, 4:30 PM ET
Smither John W
Director
Sale$40,512Sep 9, 4:30 PM ET
Kastelein Johannes Jacob Pieter
Chief Scientific Officer, Director
Sale$3,363,750Aug 25, 4:30 PM ET
Kooij Louise Frederika
Chief Accounting Officer
Sale$3,185,656Jul 22, 4:05 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
Couldn’t load funds
This read is unavailable. Try it again without changing anything on the page.
News
Stories that named NAMS, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about NAMS.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on NAMS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the NAMS board